the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

Frank J. West

Frank J. West

Partner ∙ US Office
E: fwest@oblon.com
T: (703) 412-7049
Join My LinkedIn Network
Download My vCard
Download Summary PDF
Download Detailed PDF

Representative Matters

  • Successfully represented Asahi Glass Company, Ltd., a Japanese glass manufacturer, and its subsidiary AFG Industries, Inc., a U.S. glass manufacturer, claiming patent infringement by Cardinal IG Co. of Asahi and AFG’s jointly owned patent relating to thin film low-emissivity coatings typically used in double-pane windows.
  • Represented client Buffalo Inc. and its subsidiary Buffalo Technology (USA) Inc., successfully appealed grant of summary judgment and permanent injunction in favor of CSIRO in a high-profile patent infringement case involving Wi-Fi technology relating to the transmission of wireless signals. This case was significant in that it was the first time that a court entered a permanent injunction in favor of a non-practicing entity since the Supreme Court’s landmark eBay decision. The Federal Circuit vacated and remanded the case.

Other representative litigations, ITC proceedings, and 35 USC 146 actions in which Mr. West has been counsel include:

  • In re Certain Semiconductor Memory Devices and Products Containing Same, 337-TA-472 (USITC) (industrial coating processes).
  • In re Certain Organic Photoconductor Drums and Products Containing Same, 337-TA-411(USITC) (industrial coating processes).
  • Eastman Kodak Co. v. Duracell, Inc.,98-cv-234 (D.D.C.) (35 USC §146 action) (consumer batteries).
  • Ramtron Int’l Corp. v. National Semiconductor Corp., 99-cv-0146 (D.D.C.) (35 USC §146 action) (ferro electric memory cells).
  • Loral Fairchild, Corp. v. Matsushita Elec. Indus. Co., Ltd., No. 91-056 (S.D.N.Y.) (semiconductor device structures and processes).
  • Mitsubishi Tanabe Pharma Corp. v. Cipla et al., 23-cv-759 (D. Del.) (pharmaceuticals).
  • Mitsubishi Tanabe Pharma Corp. v. Apotex et al., 24-cv-549 (D. Del.) (pharmaceuticals).
  • Mitsubishi Tanabe Pharma Corp. v. Cipla et al., 24-cv-1423 (D. Del.) (pharmaceuticals).
  • Astellas Pharma, Inc. v. Sandoz, Inc.,07-cv-1721 (N.D. Ill.) (pharmaceuticals).
  • Glaxowellcome v. Ben Venue Labs,96-cv-0278 (N.D. Ohio) (pharmaceuticals).
  • Kyorin, Senju and Allergan v. Apotex, 07-cv-779 (D. Del.) (pharmaceuticals).
  • Sigma Tau Industrie Farmaceutiche Riunite, S.p.A. v. Lonza, 97-cv-0562 (D.D.C.) (pharmaceuticals)
  • Smithkline Beecham v. Sumika Fine Chemicals, 01-cv-2602 (E.D. Pa.) (pharmaceuticals).
  • Zambon Group S.p.A. v. Pfizer, Inc., et al. ,03-cv-5334 (D.N.J.) (pharmaceuticals).
  • Zambon Group v. Teva, 04-cv-1157 (D.D.C.) (pharmaceuticals).
  • Univ. of Mass. v. Roslin Institute, 05-cv-353 (D.D.C.) (35 U.S.C. §146 action) (cloning biological material)
  • Lupin Ltd. v. Astellas Pharma, Inc.,06-cv-400 (E.D. Va.) (pharmaceuticals).
  • Plastic Omnium Advanced Innovation and Research v. Donghee America, Inc. et al. 16-cv-00187 (D. Del.) (fuel tanks).
  • Linex Technology, Inc. v. Buffalo Technology (USA), Inc., 07-cv-222 (E.D. Tex.) (wireless communication chips and processes).
  • SanDisk Corp. v. MELCO Holdings, Inc., 07-cv-605 (W.D. Wis.) (flash memory).
  • Moore North America, Inc. v. The Standard Register Co., Inc.,98-cv-485 (W.D.N.Y.) (paper products).
  • Optimumpath, LLC v. Buffalo, Inc.,09-cv-1398 (N.D. Cal.) (wireless communication chips and processes).
  • Wi-Lan, Inc. v. Buffalo Technology (USA), Inc.,07-cv-473 (E.D. Tex.) (wireless communication chips and processes).
  • Buyer's Direct Inc. v. Dick's Sporting Goods, Inc. et al., 5-18-cv-00597 (EDNC)(design patent on footwear).
  • Buyer's Direct Inc. v. Belk, Inc. et al., 5-18-cv-00582 (EDNC) design patent on footwear).